Literature DB >> 26072439

Management of Ventricular Arrhythmias in Patients with Mechanical Ventricular Support Devices.

Chris Healy1, Juan F Viles-Gonzalez, Frederic Sacher, James O Coffey, Andre d'Avila.   

Abstract

The use of mechanical ventricular support devices in the management of patients with advanced heart failure continues to increase. These devices have been shown to prolong life as a destination therapy and to increase survival when used as a bridge to transplantation. However, they are associated with a high rate of complications, including bleeding, infection, device malfunction, and ventricular arrhythmias (VAs). The mechanical support provided by the device typically allows for VAs to be well tolerated in the acute setting, though there are numerous long-term complications related to VAs such as ventricular remodeling, right ventricular failure in patients with left ventricular assist devices, and possibly increased mortality. Controversy exists as to the appropriate role of implantable cardioverter defibrillators in these patients. This review will focus on the management options available for patients with mechanical ventricular support devices and VAs.

Entities:  

Mesh:

Year:  2015        PMID: 26072439     DOI: 10.1007/s11886-015-0617-5

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  49 in total

1.  Fifteen-month circulatory support for sustained ventricular fibrillation by left ventricular assist device.

Authors:  Motonobu Nishimura; Masanori Ogiwara; Masayuki Ishikawa; Syogo Yatsu; Ayumu Masuoka; Nobuyuki Okamura; Kazuhito Imanaka; Masaaki Kato; Haruhiko Asano; Shunei Kyo
Journal:  J Thorac Cardiovasc Surg       Date:  2003-10       Impact factor: 5.209

2.  Left ventricular assist device (LVAD) enables survival during 7 h of sustained ventricular fibrillation.

Authors:  Sacha P Salzberg; Mario L Lachat; Gregor Zünd; Marko I Turina
Journal:  Eur J Cardiothorac Surg       Date:  2004-08       Impact factor: 4.191

3.  Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator.

Authors:  Daniel J Cantillon; Khaldoun G Tarakji; Dharam J Kumbhani; Nicholas G Smedira; Randall C Starling; Bruce L Wilkoff
Journal:  Heart Rhythm       Date:  2010-01-04       Impact factor: 6.343

4.  Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.

Authors:  Rakesh Gopinathannair; Emma J Birks; Jaimin R Trivedi; Kelly C McCants; Brad S Sutton; Allen G Deam; Mark S Slaughter; Rashmi U Hottigoudar
Journal:  J Card Fail       Date:  2014-12-17       Impact factor: 5.712

5.  Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial.

Authors:  Valentina Kutyifa; Wojciech Zareba; Scott McNitt; Jagmeet Singh; William Jackson Hall; Slava Polonsky; Ilan Goldenberg; David T Huang; Bela Merkely; Paul J Wang; Arthur J Moss; Helmut Klein
Journal:  Eur Heart J       Date:  2012-10-10       Impact factor: 29.983

6.  Meta-analysis of antiarrhythmic drug trials.

Authors:  S J Connolly
Journal:  Am J Cardiol       Date:  1999-11-04       Impact factor: 2.778

7.  Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias.

Authors:  Daniel P Mulloy; Castigliano M Bhamidipati; Matthew L Stone; Gorav Ailawadi; James D Bergin; Srijoy Mahapatra; John A Kern
Journal:  J Thorac Cardiovasc Surg       Date:  2012-04-20       Impact factor: 5.209

8.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

9.  Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

10.  Clinical observations and outcome of ventricular tachycardia ablation in patients with left ventricular assist devices.

Authors:  Bengt Herweg; Arzu Ilercil; Olga Kristof-Kuteyeva; Debbie Rinde-Hoffman; Christiano Caldeira; Devanand Mangar; Rachel Karlnosky; S Serge Barold
Journal:  Pacing Clin Electrophysiol       Date:  2012-09-04       Impact factor: 1.976

View more
  7 in total

Review 1.  Current Review of Implantable Cardioverter Defibrillator Use in Patients With Left Ventricular Assist Device.

Authors:  Jacinthe Boulet; Emmanuelle Massie; Blandine Mondésert; Yoan Lamarche; Michel Carrier; Anique Ducharme
Journal:  Curr Heart Fail Rep       Date:  2019-12

Review 2.  [Recommendations for emergency management of patients with permanent mechanical circulatory support : Consensus statement of DGTHG, DIVI, DGIIN, DGAI, DGINA, DGfK and DGK].

Authors:  Kevin Pilarczyk; Udo Boeken; Andreas Beckmann; Andreas Markewitz; P Christian Schulze; Martin Pin; Ingo Gräff; Sebastian Schmidt; Birk Runge; Hans-Jörg Busch; Michael R Preusch; Nils Haake; Gereon Schälte; Jan Gummert; Guido Michels
Journal:  Anaesthesist       Date:  2020-04       Impact factor: 1.041

3.  ICD shocks in LVAD patients are not associated with increased subsequent mortality risk.

Authors:  Aswini Kumar; Varun Tandon; David M O'Sullivan; Edmond Cronin; Jason Gluck; Jeffrey Kluger
Journal:  J Interv Card Electrophysiol       Date:  2019-09-10       Impact factor: 1.900

Review 4.  Implantable Cardioverter-defibrillator Therapy in the Patient with a Left Ventricular Assist Device: Still a Black Box.

Authors:  Travis Richardson; Christopher R Ellis
Journal:  J Innov Card Rhythm Manag       Date:  2017-12-15

Review 5.  Continuous-flow left ventricular assist device: Current knowledge, complications, and future directions.

Authors:  Javier Castrodeza; Carlos Ortiz-Bautista; Francisco Fernández-Avilés
Journal:  Cardiol J       Date:  2021-12-30       Impact factor: 2.737

6.  Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.

Authors:  Travis D Richardson; Leslie Hale; Christopher Arteaga; Meng Xu; Mary Keebler; Kelly Schlendorf; Matthew Danter; Ashish Shah; JoAnn Lindenfeld; Christopher R Ellis
Journal:  J Am Heart Assoc       Date:  2018-02-23       Impact factor: 5.501

Review 7.  Facilitating noncardiac surgery for the patient with left ventricular assist device: A guide for the anesthesiologist.

Authors:  Kai-Yin Hwang; Nian-Chih Hwang
Journal:  Ann Card Anaesth       Date:  2018 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.